Beilstein J. Org. Chem. 2012, 8, 413–420.
(65 mg, 0.23 mmol), NaH (30 mg, 0.75 mmol), 7 (150 mg, Prepared according to the general procedure by using a donor
0.330 mmol)/9 (182 mg, 0.325 mmol), DMF (18 mL). Yield: mixture: Compound 3 (70 mg, 0.25 mmol), NaH (30 mg, 0.75
22 mg (0.031 mmol, 14%), yellow sirup.
CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.42–7.27 (m, 20H, (20 mL). Yield: 34 mg (0.042 mmol, 20%). Relative yield 35:38
Har), 4.99 (d, JC(4’)OCH2Ph-A,B = 11.6 Hz, 1H, C(4’)-O-CH2-Ph- = 85:15. Slightly yellow sirup. +53.4 (c 0.70, CHCl3);
−106 (c 0.31, mmol), 7 (170 mg, 0.375 mmol)/8 (208 mg, 0.372 mmol), DMF
A), 4.93 (d, JC(2’)OCH2Ph-A,B = 10.7 Hz, 1H, C(2’)-O-CH2-Ph- 1H NMR (400 MHz, CDCl3) δ 7.34–7.19 (m, 25H, Har),
A), 4.91 (d, JC(3)OCH2Ph-A,B = 11.3 Hz, 1H, C(3)-O-CH2-Ph- 4.89–4.84 (m, 3H, -O-CH2-Ph), 4.73–4.61 (m, 5H, H-1,
A), 4.86 (d, 1H, C(3)-O-CH2-Ph-B), 4.79 (d, JC(3’)OCH2Ph-A,B = -O-CH2-Ph), 4.52 (d, 1H, -O-CH2-Ph), 4.41–4.31 (m, J1’,2’ =
11.7 Hz, 1H, C(3’)-O-CH2-Ph-A), 4.76 (d, 1H, C(2’)-O-CH2- 7.5 Hz, 3H, H-1’, -O-CH2-Ph), 4.09–4.01 (m, 1H, H-6A),
Ph-B), 4.72 (d, 1H, C(3’)-O-CH2-Ph-B), 4.69 (d, 1H, C(4’)-O- 3.83–3.80 (m, 1H, H-4), 3.77 (dd~vt, 1H, H-2’), 3.73–3.66 (m,
CH2-Ph-B), 4.36 (d, J1’,2’ = 7.5 Hz, 1H, H-1’), 4.19 (d, J1,2 = 2H, H-5’, H-6B), 3.56–3.42 (m, 7H, H-2, H-3, H-3’, H-4’, H-5,
7.5 Hz, 1H, H-1), 4.15 (dd, J6A,6B = 11.0 Hz, 1H, H-6A), H-6’A/B), 3.29 (s, 1H, -OCH3) ppm; 13C NMR (100 MHz,
3.86–3.79 (m, 3H, H-2’, H-4, H-6B), 3.57–3.38 (m, J5,6A = 4.1 CDCl3) δ 138.7, 138.7, 128.5, 128.4, 128.4, 128.3, 128.2,
Hz, J5’,6A = 6.6 Hz, 6H, H-2, H-3, H-3’, H-4’, H-5, H-5’), 3.51 128.1, 128.1, 128.0, 127.9, 127.8, 127.6, 127.5, 127.5 (Car),
(s, 1H, -OCH3), 1.17 (d, 3H, H-6’) ppm; 13C NMR (100 MHz, 104.2 (C-1’), 99.3 (C-1), 82.7 (C-3), 82.3 (C-3’), 79.3 (C-2’),
CDCl3) δ 138.7, 138.6, 138.5, 138.5, 138.4, 128.7, 128.5, 75.2, 74.9, 74.5, 73.6, 73.0 (-O-CH2-Ph), 73.5 (C-4), 73.5
128.5, 128.4, 128.3, 128.2, 128.1, 128.0, 127.9, 127.9, 127.8, (C-4’), 72.6 (C-2), 70.8 (C-5), 70.2 (C-5’), 69.2 (C-6), 68.7
127.6 (Car), 104.0 (C-1’), 103.7 (C-1), 83.5 (C-3) 82.4 (C-3’), (C-6’), 55.3 (-OCH3) ppm; HRMS–ESI (m/z): [M + Na]+ calcd
79.0 (C-2’), 76.2 (C-4’), 75.2, 74.7, 74.6, 73.2 (-O-CH2-Ph), for C48H54O11Na, 829.3564; found, 829.3545.
74.6 (C-5), 73.9 (C-2), 70.8 (C-4), 70.6 (C-5’), 69.1 (C-6), 56.9
(-OCH3), 16.7 (-CH3) ppm; HRMS–ESI (m/z): [M + Na]+ calcd Methyl 3-O-benzyl-6-O-(2,3,4,6-tetra-O-benzyl-β-D-galac-
for C41H48O10Na, 723.3145; found, 723.3136.
topyranosyl)-β-D-glucopyranoside (39): Prepared according
to the general procedure by using a donor mixture: Compound 4
Methyl 3-O-benzyl-6-O-(2,3,4-tri-O-benzyl-β-L-fucopyra- (65 mg, 0.23 mmol), NaH (29 mg, 0.73 mmol), 7 (151 mg,
nosyl)-β-D-galactopyranoside (37): Prepared according to the 0.334 mmol)/8 (175 mg, 0.313 mmol), DMF (16 mL). Yield:
general procedure. Compound 5 (72 mg, 0.25 mmol), NaH 8.6 mg (0.011 mmol, 5%). Yellow sirup.
−9.6 (c 0.40,
(26 mg, 0.65 mmol), 7 (343 mg, 0.731 mmol), DMF (10 mL). CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.31–7.19 (m, 25H,
Yield: 58 mg (0.083 mmol, 33%), colourless solid, mp 98 °C. Har), 4.88–4.82 (m, 3H, -O-CH2-Ph), 4.74–4.69 (m, 2H,
+72 (c 0.2, CHCl3); 1H NMR (400 MHz, CDCl3) δ -O-CH2-Ph), 4.66–4.62 (m, 2H, -O-CH2-Ph), 4.52 (d, 1H,
7.42–7.25 (m, 20H, Har), 4.99 (d, 1H, -O-CH2-Ph), 4.90 (d, 1H, -O-CH2-Ph), 4.42–4.30 (m, 2H, -O-CH2-Ph), 4.37 (d, J1,2 = 3.5
-O-CH2-Ph), 4.82–4.75 (m, J1,2 = 4.0 Hz, 3H, H-1, -O-CH2- Hz, 1H, H-1), 4.08–4.03 (m, J6A,6B = 10.8 Hz, 1H, H-6A), 4.06
Ph), 4.73 (d, 1H, -O-CH2-Ph), 4.71 (d, 1H, -O-CH2-Ph), 4.56 (s, (d, J1’,2’ = 7.6 Hz, 1H, H-1’), 3.82–3.80 (m, 1H, H-4),
2H, -O-CH2-Ph), 4.40 (d, J1’,2’ = 7.8 Hz, 1H, H-1’), 4.16–4.13 3.78–3.74 (m, 1H, H-2), 3.74 (dd, 1H, H-6B), 3.56–3.42 (m,
(m, 1H, H-4), 4.01 (dd, J6A,6B = 8.8 Hz, 1H, H-6A), 3.98 (dd, J5,6B = 6.0 Hz, 6H, H-3, H-4’, H-5, H-5’, H-6’A/B), 3.39 (dd,
J2,3 = 9.8 Hz, 1H, H-2), 3.93–3.89 (m, J5,6A = 4.3 Hz, J5,6B = J2’,3’ = 9.8 Hz, 1H, H-2’), 3.36 (s, 1H, -OCH3), 3.31 (dd~vt,
8.6 Hz, 1H, H-5), 3.86 (dd, 1H, H-6B), 3.82 (dd, J2’,3’ = 9.5 Hz, 1H, H-3’) ppm; 13C NMR (100 MHz, CDCl3) δ 138.6, 128.6,
1H, H-2’), 3.62–3.55 (m, 2H, H-3, H-4’), 3.53 (dd, J3’,4’ = 3.0 128.4, 128.4, 128.3, 128.3, 128.2, 128.2, 128.2, 128.1, 128.0,
Hz, 1H, H-3’), 3.51–3.44 (m, J5’,6’ = 6.5 Hz, 1H, H-5’), 3.39 (s, 127.9, 127.8, 127.8, 127.6, 127.5 (Car), 104.0 (C-1), 103.6
3H, OCH3), 1.19 (d, 3H, H-6’) ppm; 13C NMR (100 MHz, (C-1’), 83.7 (C-3’), 82.2 (C-3), 79.1 (C-2), 75.2, 74.7, 74.5,
CDCl3) δ 128.6, 128.5, 128.4, 128.3, 127.9, 127.8, 127.6, 73.5, 72.9 (-O-CH2-Ph), 73.5 (C-4), 74.6 (C-5), 74.2 (C-2’),
127.6, 127.6 (Car), 103.9 (C-1’), 99.5 (C-1), 82.5 (C-3’), 79.4 73.4 (C-4), 71.4 (C-5’), 69.3 (C-6), 68.7 (C-6’), 57.1 (-OCH3)
(C-2’), 78.4 (C-3), 76.2 (C-4’), 75.1, 74.6, 73.2, 71.7 (-O-CH2- ppm; MALDI–TOF–MS (DHB, positive mode; m/z): [M + Na]+
Ph), 70.5 (C-5’), 68.6 (C-2), 68.1 (C-5), 67.3 (C-6), 66.0 (C-4), calcd for C48H54O11Na, 829.36; found, 830.1.
55.4 (OCH3), 16.8 (C-6’) ppm; HRMS–ESI (m/z): [M + Na]+
References
1. Matwiejuk, M.; Thiem, J. Chem. Commun. 2011, 47, 8379–8381.
calcd for C41H48O10Na, 723.3135; found, 723.3140.
Methyl 3-O-benzyl-6-O-(2,3,4,6-tetra-O-benzyl-β-D-galac-
2. Matwiejuk, M.; Thiem, J. Eur. J. Org. Chem. 2011, 5860–5878.
topyranosyl)-α-D-glucopyranoside (38): (a) Prepared
according to the general procedure: Compound 3 (70 mg,
3. Matwiejuk, M.; Thiem, J. Eur. J. Org. Chem. 2012.
0.25 mmol), NaH (32 mg, 0.80 mmol), 8 (415 mg, 0.742
mmol), DMF (20 mL). Yield: 20 mg (0.025 mmol, 10%). (b)
419